by Ashley | Apr 21, 2020 | COVID-19, FDA Approved Clinical Trial, Personalized Stem Cells, Press Release, Stem Cell Therapy
Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named...